CXCL13 and benign prostatic hyperplasia: Future studies that employ single-cell profiling of active chromatin (e.g., by ATAC-seq) (28) may reveal the processes regulating IGF1 and CXCL13 expression in BPH fibroblasts, and whether these reflect normal embryonic patterns or focal responses, for example to hormonal changes, inflammation, or aging.